e-ISSN: Pending
Negative / Null Result Report

Effect of Delayed Initiation of Mepolizumab on Exacto Scale Scores, Clinical Remission Separ-Remas Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study

León-Lloreda A; Muñoz-Sánchez B; Polonio-González M; Echavarría-Kashmiri DC; Ferrer-Galván M; Romero-Falcón A; Maestre-Sánchez MV; Medina-Gallardo JF · 2026 · Preprint

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract (excerpt)

INTRODUCTION: Delayed initiation of mepolizumab may influence long-term disease control and the achievement of clinical and functional outcomes in patients with uncontrolled severe asthma (SUA), but no definitive conclusions have yet been…

Excerpt shown for reference under fair use — read the full paper at the publisher.

Read full paper at publisher

Hosted by the publisher — may require access.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: Europe PMC · DOI 10.20944/preprints202606.0712.v1